NewCo Ventures

Ownership

Private

Employees

~10000

Therapeutic Areas

Rare DiseasesOncology

Stage

Preclinical

Modalities

Small moleculeLarge molecule

NewCo Ventures General Information

Early-stage company focused on developing molecules for oncology and rare diseases through partnerships with pharma companies

Contact Information

Website

Primary Industry

Biotech

Corporate Office

Drug Pipeline

No pipeline data available

For full access to NewCo Ventures's pipeline data

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

NewCo Ventures Funding

Deal Type	Date	Amount	Status	Stage

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

To view NewCo Ventures's complete valuation and funding history, request access »

NewCo Ventures Investors

Funding mentioned but specific investors are not named except that funding exists for first start-up/spin-out ("Cheetah Therapeutics")[3].

Investor Type: Venture Capital

Holding: Minority